EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $355,093 | +48.0% | 22,517 | +423.7% | 0.00% | 0.0% |
Q3 2021 | $240,000 | -79.3% | 4,300 | -84.1% | 0.00% | -66.7% |
Q2 2021 | $1,160,000 | -75.1% | 27,100 | -75.7% | 0.00% | -76.9% |
Q1 2021 | $4,662,000 | +22.1% | 111,700 | +36.2% | 0.01% | +30.0% |
Q4 2020 | $3,819,000 | +495.8% | 82,000 | +443.0% | 0.01% | +400.0% |
Q3 2020 | $641,000 | +15.1% | 15,100 | +30.2% | 0.00% | 0.0% |
Q2 2020 | $557,000 | -5.6% | 11,600 | +9.4% | 0.00% | +100.0% |
Q2 2019 | $590,000 | +82.7% | 10,600 | +65.6% | 0.00% | 0.0% |
Q1 2019 | $323,000 | -28.9% | 6,400 | +6.7% | 0.00% | 0.0% |
Q2 2018 | $454,000 | +58.7% | 6,000 | +25.0% | 0.00% | 0.0% |
Q3 2017 | $286,000 | +10.0% | 4,800 | +45.5% | 0.00% | 0.0% |
Q2 2017 | $260,000 | -92.0% | 3,300 | -91.0% | 0.00% | -94.7% |
Q4 2015 | $3,236,000 | -27.6% | 36,491 | -39.4% | 0.02% | -32.1% |
Q3 2015 | $4,470,000 | +407.4% | 60,200 | +452.3% | 0.03% | +300.0% |
Q2 2015 | $881,000 | – | 10,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |